MCI Onehealth - Dr. Alexander Dobranowski, Founder, CEO and Director
Dr. Alexander Dobranowski, Founder, CEO and Director
Source: investor.mcionehealth.com
  • MCI Onehealth Technologies (DRDR) will be participating in the Biome Summit on Thursday, October 7
  • The conference is open to the public virtually and will be broadcast live
  • MCI Onehealth CEO and co-founder Dr. Alexander Dobranowski will be speaking alongside other industry leaders and medical experts
  • MCI Onehealth is a healthcare technology company that empowers patients and doctors with technologies to increase access, improve quality and reduce healthcare costs
  • MCI Onehealth is down 4.5 per cent today trading at $2.10 per share at 2:41 p.m. ET

MCI Onehealth Technologies (DRDR) will be participating in the Biome Summit on Thursday, October 7.

This year’s conference will be held virtually from 9:10 a.m. – 10:30 a.m. ET.

The conference is open to the public and will be broadcast live.

CEO and co-founder of MCI Onehealth, Dr. Alexander Dobranowski, will be speaking alongside other industry leaders and medical experts on a panel discussing a new transformational approach to cardiovascular disease (CVD).

Dr. Dobranowski will be a part of the “Better population is better healthcare- moving towards a preventative CVD paradigm” panel bringing a fresh perspective on patient care, precision medicine, AI technology and MCI Onehealth’s own clinical network.

In the past year, MCI Onehealth insiders were buying shares but not selling. The average buy price was approximately $4.03 per share

Cardiovascular disease (CVD) is one of the leading causes of death in Canada.

Early detection and management of high blood pressure, diabetes and high cholesterol can help reduce the risk of heart disease.

The Biome Summit is designed to generate ideas and diverse perspectives from some of the top minds in the health and medical field.

MCI Onehealth is a healthcare technology company that focuses on empowering patients and doctors with technologies to increase access, improve quality and reduce healthcare costs.

MCI Onehealth is down 4.5 per cent today trading at $2.10 per share at 2:41 p.m. ET.

More From The Market Online

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.
Scientific labratory

How a small-cap tech stock is broadening MRI technology 

Nanalysis Scientific (TSXV:NSCI) develops and makes compact MRI and nuclear magnetic resonance devices for clinical, lab and industrial use.

Buzz on the Bullboards: Looking for volatility-proof stocks?

Investors saw developments in Canadian and U.S. stock markets, with attention on decisions made by central banks and moves in key sectors.